The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $3,965,489.86 Indefinite Delivery Contract (IDIQ) to The Broad Institute, Inc., a non-profit biomedical and genomic research organization. The contract is for the Genomic Characterization Center program and has a completion date of September 9, 2026. The Broad Institute will provide genomic sequencing, data analysis, genome engineering, computational biology, and other scientific services to support the program, which is not set aside for any specific business category. The Broad Institute frequently collaborates with academia, healthcare, and industry partners on federally-funded research projects across areas such as cancer, neuroscience, and infectious disease.
Generated 5/19/24, 9:11 AM